Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 7
Submit an article Journal homepage
70
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Post-Bone Marrow Transplant Acute Graft-Versus-Host Disease with a Rationally Designed JAK3 Inhibitor

Marina Cetkovic-Cvrlje Experimental BMT Program, Parker Hugher Cancer Center, St. Paul, MN 55113, USA
,
Bertram A. Roers Experimental BMT Program, Parker Hugher Cancer Center, St. Paul, MN 55113, USA
,
Dawn Schonhoff Department of Immunology, Parker Hughes Institute, St. Paul, MN 55113, USA
,
Barbara Waurzyniak Department of Pathology, Parker Hughes Institute, St. Paul, MN 55113, USA
,
Xing-Ping Liu Department of Chemistry, Parker Hughes Institute, St. Paul, MN 55113, USA
&
Fatih M. Uckun Drug Discovery Program, Parker Hughes Institute, St. Paul, MN 55113, USA
Pages 1447-1453 | Published online: 01 Jul 2009

  • O'Reilly, R.J. and Papadopoulos. E.B. (1997) Allogeneic Transplantation. 4th Ed. (William and Wilkins. Baltimore) Vol. 1.
  • Ferrera, J.L.M., Deeg, H.J. and Burakoff. S.J. (1997) Graft-versusHost Disease (Marcell Decker, New York).
  • Henslee-Downey, P.J. (1995) "Mismatched bone marrow transplantation", Curr. Opin. Oncol. 7, 115-121.
  • Leelasiri. A., Greer, J.P., Stein. R.S., Goodman. S., Brandt, S.A., Edwards, J.R. and Wolff, S.N. (1995) "Graft-versus-host disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone", Bone Marrow Transplant. 15, 401-405.
  • O'Reilly, R.J. (1983) "Allogeneic bone marrow transplantation: current status and future directions". Blood 62, 941-964.
  • Leonard, W.J. and O'Shea, J. J. (1998) "Jaks and stats: biological implications", Anna. Rev Immunol. 16, 293-322.
  • Saemana, M.D., Zeyda, M., Diakos, C, Szekeres, A., Bohmig, G.A., Kelemen, P., Parolini, O., Stockinger, H., Prieschl, E.E., Stulnig, T.M., Baumruker, T. and Zlabinger. G.J. (2002) "Pharmacological targeting of JAK3 impairs early T-cell receptor (TCR)-triggeied cellular activation", Blood, In press.
  • Tomita, K., Saijo, K., Yamasaki, S., Lida. T., Nakatsu, E. Arase, H., Ohno, H., Shirasawa, T., Kuriyama. T., O'Shea, J.J. and Saito. T. (2001) "Cytokine-independent Jak3 activation upon T-cell receptor (TCR) stimulation through direct association of Jak3 and the TCR complex", J. Biol. Chem. 276, 25378-25385.
  • Thomis, D.C., Aramburu, J. and Berg, L.J. (1999) "The JAK family tyrosine kinase JAK3 is required for IL-2 synthesis by naive/resting CD4+ T-cells". J. Immunol. 163, 5411-5417.
  • Cetkovic-Cvrlje, M., Roers. B.A., Waurzyniak, B., Liu. X.P. and Uckun, P.M. (2001) 'Targeting Janus Kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice", Blood 98, 1607-1613.
  • Nosaka, T.J., van Deursen, M., Tripp, R.A., Thierfelder, W.E., Witthuhn, B.A., McMickle, A.P., Doherty. P.C., Grosveld, G.C. and Ihle, J.N. (1995) "Defective lymphoid development in mice lacking Jak3", Science 270, 800-802.
  • Gurniak, C.B., Thomis,. D.C. and Berg, L.J. (1997) "Genomic structure and promoter region of the marine Janus-family tyrosinc kinase, Jak3". DNA Cell Biol, 16, 85-94.
  • Bryson, J.S., Jennings, C.D., Caywood, B.E., Dix, A.R., Lowery. D.M. and Kaplan, A.M. (1997) "Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation". Bone Marrow Transplant. 19, 721-728.
  • Ghosh, S., Jennissen, J.D., Liu, X.P. and Uckun. F.M. (2001) "4-(3Bromo4-hydroxyphenylamino)-6,7-dimethoxyquinazolin-l-ium chloride methanol solvate and 4-(3-(hydroxyphenyl)amino)-6,7dimethoxy-l-quinazoliniurn chloride", Acta Crystallogr. C 57, 76-78.
  • Chen, C.L., Malaviya, R., Navara, C., Chen, H., Bechard. B., Mitchcltree, G., Liu. X.P. and Uckun, F.M. (1999) "Phannacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice". Pharm. Res. 161, 117-122.
  • Ihle, J.N. and Kerr, I.R. (1995) "Jaks and Stats in signaling by the cytokine receptor superfamily", Trend Genet 11, 69-74.
  • Park, S.Y., Saijo, K., Takahashi, T., Osawa, M., Arase, H., Hirayama, N., Miyake, K., Nakauchi, H., Shirasawa. T. and Saito, T. (1995) "Developmental defects of lymphoid cells in Jak3 kinasedeflcient mice", Immunity 3, 771-782.
  • Thomis, D.C., Gumiak, C.B., Tivol, E., Sharpe, A.M. and Berg, L.J. (1995) "Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3", Science 270, 794-797.
  • Murphy, W.J. and Blazar, B.R. (1999) "New strategies for preventing graft-versus host disease", Curr. Opin. Immunol. 11. 509-515.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.